Article
Usefulness of immunohistochemistry for the detection of the BRAF V600E mutation in ovarian serous borderline tumors.
Oncology reports - 1 Nov 2014
Hayashi Yuko, Sasaki Hidefumi, Takeshita Sho, Nishikawa Ryutaro, Nishikawa Hiroshi, Arakawa Atsushi, Yamashita Yoriko, Takahashi Satoru, Sugiura-Ogasawara Mayumi
Abstract excerpt
Serous borderline tumors and low-grade serous adenocarcinomas typically exhibit a low mitotic index and are largely resistant to chemotherapy. They are characterized by specific mutations, including mutations of KRAS and BRAF, which target specific cell signaling pathways. Mutational analyses may provide further insight into the development sequence of low-grade serous carcinomas. There are 3 methods to detect...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
